Investment for companies developing digital pathology solutions has spiked to more than $1.7B since 2014, with 42.4% of this total funding ($741.8M) raised during 2021. Only...
We expect pharmaceuticals companies under our coverage to report healthy Ebitda growth of 19% YoY (down 8% QoQ), mainly aided by steady domestic growth and new...
In 2023, can expect a rising volume of deals, and a surge in mergers and acquisitions 2022 was an extraordinarily challenging year. Russia’s invasion of Ukraine...
Copyright © 2023 Medical Buyer